These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15561422

  • 1. Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.
    Joel D, Doljansky J, Roz N, Rehavi M.
    Neuroscience; 2005; 130(1):25-36. PubMed ID: 15561422
    [Abstract] [Full Text] [Related]

  • 2. 'Compulsive' lever pressing in rats is enhanced following lesions to the orbital cortex, but not to the basolateral nucleus of the amygdala or to the dorsal medial prefrontal cortex.
    Joel D, Doljansky J, Schiller D.
    Eur J Neurosci; 2005 Apr; 21(8):2252-62. PubMed ID: 15869522
    [Abstract] [Full Text] [Related]

  • 3. The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system.
    Schilman EA, Klavir O, Winter C, Sohr R, Joel D.
    Neuropsychopharmacology; 2010 Mar; 35(4):1026-39. PubMed ID: 20072118
    [Abstract] [Full Text] [Related]

  • 4. The effects of temporary inactivation of the orbital cortex in the signal attenuation rat model of obsessive compulsive disorder.
    Joel D, Klavir O.
    Behav Neurosci; 2006 Aug; 120(4):976-83. PubMed ID: 16893303
    [Abstract] [Full Text] [Related]

  • 5. The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder.
    Flaisher-Grinberg S, Klavir O, Joel D.
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):811-25. PubMed ID: 18339223
    [Abstract] [Full Text] [Related]

  • 6. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S, Harvey BH.
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [Abstract] [Full Text] [Related]

  • 7. High frequency stimulation and pharmacological inactivation of the subthalamic nucleus reduces 'compulsive' lever-pressing in rats.
    Klavir O, Flash S, Winter C, Joel D.
    Exp Neurol; 2009 Jan; 215(1):101-9. PubMed ID: 18951894
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K, Aoki M.
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [Abstract] [Full Text] [Related]

  • 9. The role of the subthalamic nucleus in 'compulsive' behavior in rats.
    Winter C, Flash S, Klavir O, Klein J, Sohr R, Joel D.
    Eur J Neurosci; 2008 Apr; 27(8):1902-11. PubMed ID: 18412611
    [Abstract] [Full Text] [Related]

  • 10. Strain differences in 'compulsive' lever-pressing.
    Brimberg L, Flaisher-Grinberg S, Schilman EA, Joel D.
    Behav Brain Res; 2007 Apr 16; 179(1):141-51. PubMed ID: 17320982
    [Abstract] [Full Text] [Related]

  • 11. 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam.
    Joel D, Ben-Amir E, Doljansky J, Flaisher S.
    Behav Pharmacol; 2004 May 16; 15(3):241-52. PubMed ID: 15187582
    [Abstract] [Full Text] [Related]

  • 12. Selective alleviation of compulsive lever-pressing in rats by D1, but not D2, blockade: possible implications for the involvement of D1 receptors in obsessive-compulsive disorder.
    Joel D, Doljansky J.
    Neuropsychopharmacology; 2003 Jan 16; 28(1):77-85. PubMed ID: 12496943
    [Abstract] [Full Text] [Related]

  • 13. The role of the cholinergic system in the signal attenuation rat model of obsessive-compulsive disorder.
    Yankelevitch-Yahav R, Joel D.
    Psychopharmacology (Berl); 2013 Nov 16; 230(1):37-48. PubMed ID: 23685859
    [Abstract] [Full Text] [Related]

  • 14. The role of NMDA receptors in the signal attenuation rat model of obsessive-compulsive disorder.
    Albelda N, Bar-On N, Joel D.
    Psychopharmacology (Berl); 2010 May 16; 210(1):13-24. PubMed ID: 20238210
    [Abstract] [Full Text] [Related]

  • 15. The signal attenuation rat model of obsessive-compulsive disorder: a review.
    Joel D.
    Psychopharmacology (Berl); 2006 Jul 16; 186(4):487-503. PubMed ID: 16718482
    [Abstract] [Full Text] [Related]

  • 16. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment.
    Keck ME, Sartori SB, Welt T, Müller MB, Ohl F, Holsboer F, Landgraf R, Singewald N.
    J Neurochem; 2005 Mar 16; 92(5):1170-9. PubMed ID: 15715667
    [Abstract] [Full Text] [Related]

  • 17. A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals.
    Andersen SL, Greene-Colozzi EA, Sonntag KC.
    Biol Psychiatry; 2010 Oct 15; 68(8):741-7. PubMed ID: 20619828
    [Abstract] [Full Text] [Related]

  • 18. High but not low frequency stimulation of both the globus pallidus and the entopeduncular nucleus reduces 'compulsive' lever-pressing in rats.
    Klavir O, Winter C, Joel D.
    Behav Brain Res; 2011 Jan 01; 216(1):84-93. PubMed ID: 20654653
    [Abstract] [Full Text] [Related]

  • 19. Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex.
    Dvorkin A, Silva C, McMurran T, Bisnaire L, Foster J, Szechtman H.
    Eur J Neurosci; 2010 Nov 01; 32(9):1552-63. PubMed ID: 20731708
    [Abstract] [Full Text] [Related]

  • 20. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A, Carmi M, Hermesh H, Shahar A, Apter A, Tyano S, Rehavi M.
    Am J Psychiatry; 1986 Mar 01; 143(3):335-9. PubMed ID: 3006522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.